Shilpa Medicare gets USFDA nod for cancer treatment injection

NEW DELHI: Shilpa Medicare Tuesday said it has received approval from the US health regulator for Irinotecan HCL injection, used for treatment of certain kind of cancers.

The company has received US Food and Drug Administration (USFDA) approval for its ANDA Irinotecan HCL injection USP in the strengths 40 mg/2mL and 100 mg/5mL (20mg/mL) single dose vials, Shilpa Medicare said in a BSE filing.

Irinotecan injection is used in the treatment of patients with metastatic carcinoma of the colon or rectum, the company added.

Quoting IQVIA MAT second quarter 2018 data, Shilpa Medicare said the US market for Irinotecan HCL is approximately USD 18 million.

Shares of Shilpa Medicare were trading 3.80 per cent up at Rs 398.65 apiece on BSE.

  • Related Posts

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta Lifestyle Private Limited announced the launch of EVERQ, an AI-powered skin-health platform designed to bring skin assessment, dermatologist consultations, personalised treatment and ongoing skincare together in one connected journey.…

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell interventions that have not been approved for routine clinical use, including those offered for autism, should not be provided as routine, standard or commercial clinical services, the advisory…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre

    US FDA launches expedited IND Pilot, begins accepting applications

    US FDA launches expedited IND Pilot, begins accepting applications

    PIL in SC seeks time-bound probe, stringent action against fake drug networks

    PIL in SC seeks time-bound probe, stringent action against fake drug networks

    Ghaziabad: Fake supplement racket busted, 5 held

    Ghaziabad: Fake supplement racket busted, 5 held

    22 medical stores raided in Hisar, 7 stocked dual-use drugs without records

    22 medical stores raided in Hisar, 7 stocked dual-use drugs without records